$6.45
+0.24 (+3.86%)
Analyst Consensus
Hold
17
Analysts
High
Coverage
Price Target
Analyst Price Target
+556.1% upside
Low Target
$27.22
Average Target
$42.32
High Target
$56.32
Current Price
$6.45
Current
$6.45
$6.45
Target
$42.32
$42.32
$27.22
$42.32 avg
$56.32
Scenario Analysis
Bear Case
$27.22
322.0%
Low target
Base Case
$42.32
+556.1%
Avg target
Bull Case
$56.32
+773.2%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$23.20
-72.2% from high
52-Week Low
$3.51
+83.8% from low
Target vs 52W High
$42.32
+82.4% vs high
Next Earnings Report
Apr 6, 2026 · Before Market Open
10d
until earnings
EPS Est: $-0.14
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |